BenQ Medical Technology (TWO:4116) — Stock Price
BenQ Medical Technology (TWO:4116) is currently trading at NT$39.80 TWD, up 0.38% today. Over the past 52 weeks, shares have ranged between NT$36.50 and NT$51.70. This page tracks BenQ Medical Technology's live share price on the TWO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 4116 stock market capitalisation.
BenQ Medical Technology (4116) Stock Price Chart — Daily History & Trading Volume
The chart below tracks BenQ Medical Technology's daily closing share price and trading volume on the TWO exchange over the past year, giving a clear view of recent price momentum and liquidity.
BenQ Medical Technology Income Statement — Revenue, Profit & Earnings by Year
BenQ Medical Technology's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | NT$4.77 Billion | NT$4.54 Billion | NT$2.95 Billion | NT$1.46 Billion | NT$1.40 Billion |
| Cost of Revenue | NT$3.32 Billion | NT$3.20 Billion | NT$2.09 Billion | NT$952.31 Million | NT$849.22 Million |
| Gross Profit | NT$1.45 Billion | NT$1.34 Billion | NT$860.25 Million | NT$512.28 Million | NT$551.63 Million |
| Research & Development | NT$36.39 Million | NT$31.96 Million | NT$39.58 Million | NT$39.65 Million | NT$44.30 Million |
| SG&A | NT$1.08 Billion | NT$947.17 Million | NT$182.13 Million | NT$122.80 Million | NT$125.32 Million |
| Total Operating Expenses | NT$4.43 Billion | NT$4.18 Billion | NT$681.13 Million | NT$463.23 Million | NT$454.29 Million |
| Operating Income | NT$333.39 Million | NT$364.77 Million | NT$286.64 Million | NT$67.48 Million | NT$109.81 Million |
| EBITDA | — | — | NT$476.65 Million | NT$168.53 Million | NT$195.40 Million |
| EBIT | — | — | NT$286.64 Million | NT$67.48 Million | NT$109.81 Million |
| Interest Expense | NT$34.22 Million | NT$27.94 Million | NT$13.51 Million | NT$3.91 Million | NT$4.02 Million |
| Income Before Tax | NT$329.38 Million | NT$373.10 Million | NT$274.89 Million | NT$61.78 Million | NT$105.67 Million |
| Income Tax Expense | — | — | NT$38.29 Million | NT$12.75 Million | NT$21.55 Million |
| Net Income | NT$104.83 Million | NT$114.58 Million | NT$180.24 Million | NT$28.84 Million | NT$62.05 Million |
BenQ Medical Technology Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes BenQ Medical Technology's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | NT$5.27 Billion | NT$4.71 Billion | NT$3.40 Billion | NT$1.96 Billion | NT$1.79 Billion |
| Total Current Assets | NT$3.10 Billion | NT$2.73 Billion | NT$1.72 Billion | NT$870.18 Million | NT$776.66 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | NT$328.98 Million | NT$366.87 Million | NT$192.20 Million | NT$51.42 Million | NT$88.43 Million |
| Net Receivables | NT$905.41 Million | NT$846.48 Million | NT$555.43 Million | NT$206.54 Million | NT$198.23 Million |
| Inventory | NT$783.12 Million | NT$515.75 Million | NT$267.14 Million | NT$211.39 Million | NT$204.56 Million |
| Property, Plant & Equipment | — | — | — | NT$742.75 Million | NT$795.08 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | NT$2.97 Billion | NT$2.53 Billion | NT$1.66 Billion | NT$855.51 Million | NT$677.80 Million |
| Total Current Liabilities | NT$1.77 Billion | NT$1.38 Billion | NT$999.35 Million | NT$463.65 Million | NT$468.15 Million |
| Long-term Debt | NT$868.95 Million | NT$843.13 Million | NT$404.00 Million | NT$331.25 Million | NT$136.28 Million |
| Net Debt | NT$671.29 Million | NT$405.72 Million | NT$204.84 Million | NT$121.90 Million | NT$48.25 Million |
| Total Stockholder Equity | NT$1.12 Billion | NT$1.10 Billion | NT$1.20 Billion | NT$1.04 Billion | NT$1.05 Billion |
| Retained Earnings | NT$380.59 Million | NT$361.81 Million | NT$457.38 Million | NT$297.44 Million | NT$313.62 Million |
BenQ Medical Technology Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how BenQ Medical Technology generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | NT$222.22 Million | NT$442.35 Million | NT$378.77 Million | NT$121.35 Million | NT$151.48 Million |
| Capital Expenditures | NT$175.48 Million | NT$139.28 Million | NT$60.05 Million | NT$32.92 Million | NT$42.37 Million |
| Free Cash Flow | NT$46.74 Million | NT$303.07 Million | NT$318.72 Million | NT$88.42 Million | NT$109.12 Million |
| Investing Cash Flow | — | — | — | NT$-98.77 Million | NT$-104.06 Million |
| Financing Cash Flow | — | — | NT$2.43 Million | NT$92.15 Million | NT$-34.99 Million |
| Dividends Paid | NT$-89.13 Million | NT$-93.59 Million | NT$22.28 Million | NT$44.57 Million | NT$60.16 Million |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | NT$255.21 Million | NT$229.22 Million | NT$190.01 Million | NT$101.04 Million | NT$85.59 Million |
| Change in Cash | NT$32.68 Million | NT$-149.28 Million | NT$277.41 Million | NT$114.80 Million | NT$12.43 Million |
BenQ Medical Technology Earnings History — EPS Actual vs. Analyst Estimates
Track BenQ Medical Technology's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 06, 2025 | — | — | — |
| May 31, 2023 | 0.51 | — | — |
| Mar 01, 2023 | 0.51 | — | — |
| Nov 30, 2022 | 0.77 | — | — |
| Aug 31, 2022 | 0.78 | — | — |
| Jun 01, 2022 | 1.96 | — | — |
| Mar 02, 2022 | 0.27 | — | — |
| Dec 01, 2021 | 0.19 | — | — |